DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $540,000 | -50.7% | 144,800 | -47.0% | 0.20% | -46.7% |
| Q3 2021 | $1,095,000 | -56.9% | 273,100 | -52.1% | 0.38% | -50.1% |
| Q2 2021 | $2,539,000 | -51.4% | 570,500 | 0.0% | 0.77% | -56.6% |
| Q1 2021 | $5,220,000 | -9.9% | 570,500 | -0.2% | 1.77% | -23.8% |
| Q4 2020 | $5,795,000 | +139.2% | 571,500 | 0.0% | 2.32% | +108.4% |
| Q3 2020 | $2,423,000 | -0.4% | 571,500 | +62.8% | 1.11% | -20.5% |
| Q2 2020 | $2,433,000 | +147.5% | 351,100 | 0.0% | 1.40% | +55.4% |
| Q1 2020 | $983,000 | -25.6% | 351,100 | +28.9% | 0.90% | +31.0% |
| Q4 2019 | $1,321,000 | +134.2% | 272,400 | 0.0% | 0.69% | +121.9% |
| Q3 2019 | $564,000 | -57.5% | 272,400 | +1.9% | 0.31% | -49.9% |
| Q2 2019 | $1,326,000 | +92.7% | 267,300 | +76.4% | 0.62% | +89.3% |
| Q1 2019 | $688,000 | +18.2% | 151,500 | -24.2% | 0.33% | +9.0% |
| Q4 2018 | $582,000 | – | 200,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
| COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
| STATE STREET CORP | 133,258 | $210,548 | 0.00% |
| MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
| BlackRock Inc. | 69,937 | $110,508 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
| Citadel Advisors | 1,600 | $2,528 | 0.00% |